Live Breaking News & Updates on Acurabio Selects Cytiva 39s Latest Two Step Purification Protocol To Offera Productive Plasmid Dna Service Its Customers Globally Alleviate Supply Constraints For Mrna And Cell Amp Gene Therapies The Technology Will Offer Efficient Processing Time Production Brisbane

AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply constraints for mRNA and cell & gene therapies The latest purification technology will offer efficient processing time for plasmid DNA production BRISBANE, Australia, Feb. 10, 2023 /PRNewswire/ AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organization (CDMO), will provide a cGMP plasmid DNA CDMO service to the world using Cytiva's new process platform technology. Jon Ince (left), General Manager, Australia & New Zealand, Cytiva and Guillaume Herry (right), CEO of AcuraBio, at the contract signing ceremony AcuraBio expects to produce more plasmid DNA for its customers around the world using Cytiva's latest bacterial plasmid two-step purification protocol. The new protocol features single-use purification technology which delivers efficiency, high purity level outcome and s ....

New Zealand , Guillaume Herry , Prnewswire Acurabio , Cytiva Flexfactory , Acurabio Pty Ltd , General Manager , Biotech Makers , Trend Summit , Global Market Report , Surging Number , Patients Choosing Gene Therapy , Their Treatment , Bio Pty Ltd , Acurabio Selects Cytiva 39s Latest Two Step Purification Protocol To Offera Productive Plasmid Dna Service Its Customers Globally Alleviate Supply Constraints For Mrna And Cell Amp Gene Therapies The Technology Will Offer Efficient Processing Time Production Brisbane , Feb 10 , 023 Prnewswire Acurabio , A Leading Australian Biopharmaceutical Contract Development And Manufacturing Organization Cdmo , Ill Providea Cgmp Plasmid Dna Cdmo Service To The World Using Cytiva 39s New Process Platform Technology Jon Ince Left , General Manager , Australia Amp New Zealand , Ytiva And Guillaume Herry Right , Eo Of Acurabio , T The Contract Signing Ceremony Acurabio Expects To Produce More Plasmid Dna For Its Customers Around World Using Cytiva 39s Latest Bacterial Two Step Purification Protocol New Features Single Use Technology Which Delivers Efficiency , Igh Purity Level Outcome And Sustainable Process 1 Guillaume Herry , Eo Of Acurabio Says Quot We Are Very Excited To Implement Cytiva 39s Latest Technology Especially Because The Access And Production Plasmid Dna Has Beena Bottleneck In Advanced Therapy Market Intend Bring Biotechs Biopharma Companiesa More High Quality Quicker Than Before Help Development New Therapies Such As Viral Vectors Mrna Jon Ince , Ustralia And New Zealand ,